Tcr2 Therapeutics Inc.

JPMORGAN CHASE & CO

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/18/2023

Shares

524,184

Value ($000)

787

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/18/2023	787	0.0%	524,184	3/31/2023
2022 Q4	2/13/2023	524	0.0%	524,184	12/31/2022
2022 Q3	11/14/2022	947	0.0%	525,748	9/30/2022
2022 Q2	8/11/2022	2,030	0.0%	699,890	6/30/2022
2022 Q1	5/11/2022	1,970	0.0%	713,613	3/31/2022
2021 Q4	2/11/2022	4,339	0.0%	930,835	12/31/2021
2021 Q3	11/12/2021	8,768	0.0%	1,030,360	9/30/2021
2021 Q2	8/12/2021	10,821	0.0%	659,411	6/30/2021
2021 Q1	5/12/2021	14,457	0.0%	654,814	3/31/2021
2020 Q4	2/19/2021	14,232	0.0%	460,147	12/31/2020
2020 Q3	11/12/2020	5,107	0.0%	263,874	9/30/2020
2020 Q2	8/11/2020	3,770	0.0%	245,559	6/30/2020
2020 Q1	5/12/2020	1,745	0.0%	225,501	3/31/2020
2019 Q4	2/11/2020	2,960	0.0%	207,304	12/31/2019